Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 49Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Myelomonocytic, Acute 11Leukemia, Monocytic, Acute 10Myelodysplastic Syndromes 7Leukemia, Erythroblastic, Acute 7Burkitt Lymphoma 7Lymphoma 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Biphenotypic, Acute 6Myeloproliferative Disorders 4Dendritic Cell Sarcoma, Interdigitating 4Thrombocytopenia 3Lymphoma, Non-Hodgkin 3Leukemia, Promyelocytic, Acute 3Congenital Abnormalities 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Philadelphia Chromosome 2Neutropenia 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Basophilic, Acute 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Neoplasms 1Lymphoma, T-Cell 1

Interventions

Prednisone 3pembrolizumab 2Melphalan 2Cytarabine 2venetoclax 1ofatumumab 1obinutuzumab 1ioflupane 1imetelstat 1ibrutinib 1gossypol acetic acid 1gilteritinib 1fluorocholine 1fluciclovine F-18 1deltacortene 1daratumumab 1aflibercept 1abiraterone 1Temozolomide 1Self-Management 1Quality of Life 1Professional Autonomy 1Paclitaxel 1Oncolytic Virotherapy 1Octreotide 1Mitoxantrone 1Methylene Blue 1Lenalidomide 1Gemtuzumab 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Disease × Daunorubicin × Clear all
NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Jazz Pharmaceuticals

Phase 2 Completed
126 enrolled 12 charts
Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡